FULC
Price
$6.87
Change
-$0.23 (-3.24%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
383.25M
37 days until earnings call
TVTX
Price
$14.79
Change
+$0.02 (+0.14%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
1.31B
31 days until earnings call
Interact to see
Advertisement

FULC vs TVTX

Header iconFULC vs TVTX Comparison
Open Charts FULC vs TVTXBanner chart's image
Fulcrum Therapeutics
Price$6.87
Change-$0.23 (-3.24%)
Volume$19.15K
Capitalization383.25M
Travere Therapeutics
Price$14.79
Change+$0.02 (+0.14%)
Volume$38.79K
Capitalization1.31B
FULC vs TVTX Comparison Chart in %
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. TVTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and TVTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (FULC: $7.10 vs. TVTX: $14.77)
Brand notoriety: FULC and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 185% vs. TVTX: 240%
Market capitalization -- FULC: $383.25M vs. TVTX: $1.31B
FULC [@Biotechnology] is valued at $383.25M. TVTX’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than TVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 5 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 5 bullish, 4 bearish.
  • TVTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FULC is a better buy in the short-term than TVTX.

Price Growth

FULC (@Biotechnology) experienced а +1.50% price change this week, while TVTX (@Biotechnology) price change was +3.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($1.31B) has a higher market cap than FULC($383M). FULC YTD gains are higher at: 51.064 vs. TVTX (-15.212). FULC has higher annual earnings (EBITDA): -8.94M vs. TVTX (-168.21M). TVTX has more cash in the bank: 322M vs. FULC (227M). FULC has less debt than TVTX: FULC (8.11M) vs TVTX (400M). TVTX has higher revenues than FULC: TVTX (274M) vs FULC (80M).
FULCTVTXFULC / TVTX
Capitalization383M1.31B29%
EBITDA-8.94M-168.21M5%
Gain YTD51.064-15.212-336%
P/E RatioN/AN/A-
Revenue80M274M29%
Total Cash227M322M70%
Total Debt8.11M400M2%
FUNDAMENTALS RATINGS
FULC vs TVTX: Fundamental Ratings
FULC
TVTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
89100
PRICE GROWTH RATING
1..100
3657
P/E GROWTH RATING
1..100
10044
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (28) in the null industry is somewhat better than the same rating for TVTX (87) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than TVTX’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as TVTX (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to TVTX’s over the last 12 months.

FULC's SMR Rating (89) in the null industry is in the same range as TVTX (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to TVTX’s over the last 12 months.

FULC's Price Growth Rating (36) in the null industry is in the same range as TVTX (57) in the Biotechnology industry. This means that FULC’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's P/E Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for FULC (100) in the null industry. This means that TVTX’s stock grew somewhat faster than FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCTVTX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 26 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPPX14.190.08
+0.57%
Goldman Sachs Strategic Growth P
WASAX23.190.09
+0.39%
Macquarie Asset Strategy Fund Cl A
PEICX21.660.06
+0.28%
PGIM Jennison Value C
LKBLX53.000.02
+0.04%
LK Balanced Institutional
BPTRX195.54-0.20
-0.10%
Baron Partners Retail

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-3.79%
SLS - FULC
48%
Loosely correlated
-3.94%
ANNX - FULC
40%
Loosely correlated
-1.63%
VRDN - FULC
39%
Loosely correlated
-1.37%
MLTX - FULC
34%
Loosely correlated
+0.32%
ITOS - FULC
34%
Loosely correlated
-0.70%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-2.38%
CRNX - TVTX
43%
Loosely correlated
-1.48%
XNCR - TVTX
43%
Loosely correlated
-3.10%
RLAY - TVTX
42%
Loosely correlated
-0.60%
COGT - TVTX
39%
Loosely correlated
-3.14%
BCYC - TVTX
39%
Loosely correlated
-0.55%
More